When COVID-19 started spreading across the country, Montefiore Health System (MHS) in the Bronx, New York, was at the epicenter, with more than 4,000 simultaneously hospitalized patients at one point. Join a panel of MHS providers for an in-depth look at their pandemic preparations and response and how they’re collecting data for care coordination and research. Plus, take away…
Editor-in-Chief: Krista Nelson, LCSW, OSW-C, FAOSW, FAPOS, FACCC Oncology Issues, Article, Volume 40, Care for underserved and marginalized populations happens more in community cancer centers…
The NCCN held a policy summit dedicated to exploring strategies to improve collaboration between primary care providers and oncologists to promote better patient outcomes.
Nestled at the foot of the mighty Rocky Mountains, Denver serves as the backdrop for the 2025 National Oncology Conference, hosted by the Association of…
While sarcomas present unique challenges in detection, treatment, and prevention, ongoing research and advocacy are paving the way for better outcomes.
Editor-in-Chief: Krista Nelson, LCSW, OSW-C, FAOSW, FAPOS, FACCC Oncology Issues, Article, Volume 40, While artificial intelligence (AI) is becoming a popular term in the headlines,…
This spring, ACCC hosted 2 virtual office hours sessions featuring oncology pharmacists with expertise in using bispecific antibodies. Participants shared practical insights, challenges, and strategies…
Editor-in-Chief: Krista Nelson, LCSW, OSW-C, FAOSW, FAPOS, FACCC Oncology Issues, Article, Volume 40, Osteosarcoma, a rare type of bone cancer that primarily affects adolescents and…
In response to the need for cancer screening and care in Appalachia, ACCC—together with several of its state chapters—launched the Appalachian Community Cancer Alliance in…
Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile,…
Join SITC and a panel of experts for an afternoon of in-depth education on all aspects of cellular therapies, T Cell Engagers and TIL Therapies
